tiprankstipranks
Defence Therapeutics (DTCFF)
OTHER OTC:DTCFF
Holding DTCFF?
Track your performance easily

Defence Therapeutics (DTCFF) Financial Statements

11 Followers

Defence Therapeutics Financial Overview

Defence Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.192; its P/E ratio is -2.44; Defence Therapeutics is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBITC$ -606.86KC$ -1.44MC$ -1.23MC$ -8.26MC$ -2.10M
EBITDAC$ -589.15KC$ -1.39MC$ -1.21MC$ -8.25MC$ -2.09M
Net Income Common StockholdersC$ -606.86KC$ -1.35MC$ -1.33MC$ -8.32MC$ -2.20M
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 131.20KC$ 56.55KC$ 514.53KC$ 351.00KC$ 1.35M
Total AssetsC$ 424.67KC$ 477.75KC$ 968.28KC$ 668.85KC$ 1.59M
Total DebtC$ 1.84MC$ 1.75MC$ 1.60MC$ 1.51MC$ 1.64M
Net DebtC$ 1.71MC$ 1.69MC$ 1.09MC$ 1.16MC$ 287.80K
Total LiabilitiesC$ 4.55MC$ 4.06MC$ 3.27MC$ 2.96MC$ 2.03M
Stockholders EquityC$ -4.12MC$ -3.58MC$ -2.30MC$ -2.30MC$ -441.54K
Cash Flow-
Free Cash FlowC$ 87.41KC$ -515.23KC$ -1.15MC$ -1.39MC$ -1.43M
Operating Cash FlowC$ 87.41KC$ -532.17KC$ -940.92KC$ -1.39MC$ -1.42M
Investing Cash Flow-C$ 16.94KC$ -213.68K-C$ -6.50K
Financing Cash FlowC$ -12.76KC$ 57.24KC$ 1.32MC$ 394.52KC$ -14.66K
Currency in CAD

Defence Therapeutics Earnings and Revenue History

Defence Therapeutics Debt to Assets

Defence Therapeutics Cash Flow

Defence Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis